Skip to main content
Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma.
Published Web Location
http://europepmc.org/articles/PMC4352456?pdf=renderNo data is associated with this publication.
Abstract
We present our initial experience in using single modality fluoromisonidazole (FMISO) PET/MR imaging to noninvasively evaluate the biological effects induced by bevacizumab therapy in a patient treated for recurrent high grade glioma. In this index patient
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.